Physiologically Based Pharmacokinetic Modeling of Nanoparticles

作者：Yuan, Dongfen; He, Hua; Wu, Yun; Fan, Jianghong; Cao, Yanguang^*

来源：Journal of Pharmaceutical Sciences, 2019, 108(1): 58-72.

DOI：10.1016/j.xphs.2018.10.037

• nanoparticle disposition
• PBPK
• mononuclear phagocytic system
• tissue distribution
• toxicity
• efficacy

Nanoparticles are frequently designed to improve the pharmacokinetics profiles and tissue distribution of small molecules to prolong their systemic circulation, target specific tissue, or widen the therapeutic The multifunctionality of nanoparticles is frequently presented as an advantage but also results in distinct and complicated in vivo disposition properties compared with a conventional formulation of the same molecules. Physiologically based pharmacokinetic (PBPK) modeling has been a useful tool in characterizing and predicting the systemic disposition, target exposure, and efficacy and toxicity of various types of drugs when coupled with pharmacodynamic modeling. Here we review the unique disposition characteristics of nanoparticles, assess how PBPK modeling takes into account the unique disposition properties of nanoparticles, and comment on the applications and challenges of PBPK modeling in characterizing and predicting the disposition and biological effects of nanoparticles.

• 出版日期2019-1
• 单位中国药科大学